Quantitative [F-18]fluorodeoxyglucose positron emission tomography in pretreatment and grading of sarcoma

Clinical Cancer Research

Volumn 4, Issue 5, 1998, Pages 1215-1220

  Eary, Janet F ^a,b   Conrad, Ernest U ^b   Bruckner, James D ^b   Folpe, Andrew ^b   Hunt, Karen J ^b   Mankoff, David A ^b   Howlett, Andrew T ^b  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER GRADING; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; SOFT TISSUE SARCOMA;

ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FLUORODEOXYGLUCOSE F18; HUMANS; MIDDLE AGED; RADIOPHARMACEUTICALS; SARCOMA; SOFT TISSUE NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031900784     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Koh, W., Griffin, T., Rasey, J., and Laramore, G. Positron emission tomography: a new tool for characterization of malignant disease and selection of therapy. Acta Oncol., 33: 323-327, 1994.
2. Rodriguez, M., Rehn, S., Ahlström, H., Sundström, C., and Glimelius, B. Predicting malignancy grade with PET in non-Hodgkin's lymphoma. J. Nucl. Med., 36: 1790-1796, 1995.
3. Adler, L., Blair, H., Makley, J., Williams, R., Joyce, M., Leisure, G., Al-Kaisi, N., and Miraldi, F. Noninvasive grading of musculoskeletal tumors using PET. J. Nucl. Med., 32: 1508-1512, 1991.
4. Griffeth, L., Dehdashti, F., McGuire, A., McGuire, D., Perry, D., Moerlein, S., and Siegel, B. PET evaluation of soft-tissue masses with fluorine-18 fluoro-2-deoxy-D-glucose. Radiology, 182: 185-194, 1992.
5. Ichiya, Y., Kuwaqbara, Y., Otsuka, M., Tahara, T., Yoshikai, T., Fukumura, T., Jiugu, K., and Masuda, K. Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography. J. Nucl. Med., 32: 1655-1660, 1991.
6. Kern, K., Burnetti, A., Norton, J., Chang, A., Malawer, M., Lack, E., Finn, R., Rosenberg, S., and Larson, S. Metabolic imaging of human extremity musculoskeletal tumors by PET. J. Nucl. Med., 29: 181-186, 1988.
7. Nieweg, O., Pruim, J., van Ginkel, R., Hoekstra, H., Paans, A., Molenaar, W., Koops, H., and Vaalburg, W. Fluorine-18-fluorodeoxyglucose PET imaging of soft-tissue sarcoma. J. Nucl. Med., 37: 257-261, 1996.
8. Costa, J., Wesley, R., Gladstein, E., and Rosenberg, S. The grading of soft tissue sarcomas. Results of clinicohistopathologic correlation in a series of 163 cases. Cancer (Phila.), 53: 530-541, 1984.
9. Angervall, L., and Kindblom, L. Principles for pathologic-anatomic diagnosis and classification of soft-tissue sarcomas. Clin. Orthop., 289: 9-18, 1993.
10. Potter, D., Kinsella, T., Gladstein, E., Wesley, R., White, D. E., Seipp, C. A., Chang, A. E., Lack, E. E., Costa, J., and Rosenberg, S. A. High-grade soft tissue sarcomas of the extremities. Cancer (Phila.), 58: 190-205, 1986.
11. Unni, K. General aspects and data on 11,087 cases. In: K. Unni (ed.), Dahlin's Bone Tumors, Ed. 5, pp. 143-183. Philadelphia: Lippincott-Raven Publishers, 1996.
12. Mankoff, D., Shields, A., Graham, M., Link, J., Eary, J., and Krohn, K. Kinetic analysis of 2-[C-11]-thymidine PET imaging studies: compartmental model and mathematical analysis. J. Nucl. Med., in press, 1997.
13. Lewellen, T. K., Kohlmeyer, S., Miyaoka, R., Schubert, S., and Stearns, C. Investigation of the count rate performance of the General Electric ADVANCE positron emission tomograph. IEEE Trans. Nucl. Sci., 42: 1051-1057, 1995.
14. Patlak, C. S., Blasberg, R. G., and Fenstermacher, J. D. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J. Cereb. Blood Flow Metab., 3: 1-7, 1983.
15. Eary, J. F., and Mankoff, D. A. Tumor metabolic rates in sarcoma using FDG PET. J. Nucl. Med., 39: 250-254, 1998.
16. 11C-methionine in breast cancer studied by PET. An association with the size of S-phase fraction. Br. J. Cancer, 64: 1121-1124, 1991.
17. Shields, A., Lim, K., Grierson, J., Link, J., and Krohn, K. Utilization of labeled thymidine in DNA synthesis: studies for PET. J. Nucl. Med., 31: 337-342, 1990.
18. Shields, A., Mankoff, D., Link, J., Graham, M., Eary, J., Kozawa, S., Zheng, M., Lewellen, B., Lewellen, T., Grierson, J., and Krohn, K. Monitoring tumor response to chemotherapy with [C-11]thymidine and FDG PET. J. Nucl. Med., 37 (Suppl. 5): 67P, 1996.